Current Clinical Trials

A clinical trial is a research study that is done to find out if medical treatments can improve people’s health. A medical treatment can be a drug, medical device, medical procedure, or a change in a person’s behavior such as diet or exercise. People who take part in clinical trials are volunteers.  They are also called “participants.”  Clinical Trials FAQs.

Find a Clinical Trial

Therapeutic Area Condition Description  
Haematology & Thrombosis
Hemophilia A CSL627_3001: An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A. Learn More
  Hemophilia B CSL654_3003: A Safety and Efficacy Extension Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B Learn More
  Hemophilia A & B CSL689_2001: Study of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) for On-demand Treatment of Bleeding Episodes in Patients With Hemophilia A or B With Inhibitors Terminated
  Congenital Fibrinogen Deficiency BI3023_4003: An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency  Completed
  Von Willebrand Disease CSLCT-BIO-12-83: Study of Voncento® in Subjects With Von Willebrand Disease Completed
  Reversal of acquired coagulation factor deficiency BE1116_4001: An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding Learn More
  Sickle Cell CSL200_1001: CSL200 Gene Therapy in Adults With Severe Sickle Cell Disease Learn More
Cardiovascular and Metabolic Acute Coronary Syndrome CSL112_3001: Study to investigate CSL112 in Subjects With Acute Coronary Syndrome (AEGIS-II) Learn More
  Coronary Heart Disease

CSL112:1001: Assessing the pharmacokinetics, safety, and tolerability of CSL112 in healthy Japanese and Caucasian adults

Completed
Immunology and Neurology  Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) IgPro20_3004: Extension Study of Maintenance Treatment with Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Results
  Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) IgPro10_5004: Evaluating the Effectiveness of Telemonitoring System in the Management of Patients With CIDP (HELIPAD 1) Learn More
  Dermatomyositis (DM) IgPro20_3007: A study to evaluate the efficacy, safety, and pharmacokinetics of IgPro20 in adults with Dermatomyositis (DM) Learn More
  Pediatric CIDP IgPro10_4002: Randomized Study of Single vs. Multiple Privigen Dose Regimens in Pediatric CIDP Learn More 
  Hereditary Angioedema (HAE) CSL312_2001: A study to Investigate CSL312 in Subjects With Hereditary Angioedema (HAE) Learn More
  Primary Immune Deficiency (PID) IgPro20_1001: Comparison of 2 Infusion Devices With Respect to Pharmacokinetics, Safety, and Tolerability of Hizentra: An Investigational Wearable Infusor and the Crono S-PID-50 Infusion Pump Learn More
  Primary Immune Deficiency (PID) IgPro20_4005: Study of Immune Deficiency Patients treated with Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly and Biweekly Schedules Results
  Primary Immune Deficiency (PID) IgPro20_4004: Safety and Tolerability of Higher Infusion Parameters of IgPro20 (Hizentra®) in Subjects With Primary Immunodeficiency (PID) Completed
  Healthy Subjects CSL730_1001: Assessing the Safety and Tolerability of CSL730 in Healthy Caucasian and Japanese Adults Learn More
  Healthy Subjects CSL324_1001: Dose escalation, placebo-controlled phase 1 study to assess the safety and tolerability of CSL324 in healthy adults Completed
 Respiratory Mild Asthma CSL311_1001: A Clinical Study to test the safety, exposure, and markers of Efficacy of CSL311 in patients with mild asthma. Learn More
Transplant Antibody-mediated kidney transplant rejection CSL842_3001: Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients Learn More
  Acute GVHD (aGVHD) CSL964_2001: The Safety and Efficacy of Alpha 1 Antitrypsin (AAT) for the Prevention of Graft‑Versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell Transplant (MODULAATE) Learn More
How to Enroll into a Study

Find out if enrolling in a clinical trial is right for you.

Learn More
Product Pipeline

Delve into our portfolio of new products, improved products and manufacturing expertise.

Learn More
Clinical Trials

Learn what a trial is and why it is important.

Learn More

Get our latest news in your inbox

mail@example.com
First name
Last name
Country

Thanks!

Thank you for subscribing
to the CSL newsletter